Product Images Venlafaxine Hydrochloride

This appears to be a list of symptoms related to suicidal thoughts and behavior, including changes in mood, behavior, and physical symptoms such as trouble sleeping and visual problems. It emphasizes the importance of seeking help if experiencing any of these symptoms.*

The table shows the incidence of treatment-emergent adverse reactions in short-term clinical trials with Venlafaxine Hydrochloride Extended-Release Capsules in patients with Major Depressive Disorder. The reactions are classified by body system and percentage of patients reporting them. The reactions with the highest percentage of reporting are abnormal ejaculation (16%), nervousness (10%), and sweating (4%). Other reactions include nausea, vomiting, constipation, weight loss, dizziness, insomnia, abnormal vision, and impotence.*

This is a report on the incidence of treatment-emergent adverse reactions in clinical trials comparing Vonlafine Hydrochloride with a placebo for patients with social anxiety disorder. The table includes data on adverse reactions in different body systems.*

This is a table that shows the difference between certain drugs and placebo in terms of the number of cases of suicidality per 1000 patients treated. The table shows that for some drugs, there is an increase in the number of cases of suicidality compared to placebo, with 14 additional cases and 5 additional cases listed. On the other hand, some drugs show a decrease compared to placebo, with 1 fewer case and 6 fewer cases listed.*

This is a table showing the percentage of sustained elevations in SDBP (systolic and diastolic blood pressure) in premarketing studies of Venlafaxine Hydrochloride Extended-Release Capsules for major depressive disorder and other clinical trials. The dosages tested were between 75 mg/day and 375 mg/day. The table includes two indications and two dosage ranges with corresponding numbers and percentages of patients experiencing sustained elevations in SDBP.*

The table shows the incidence of insomnia and nervousness in placebo-controlled trials for major depressive disorder using venlafaxine hydrochloride extended-release capsules compared to a placebo. The data suggests that these symptoms were more commonly reported in patients taking venlafaxine hydrochloride extended-release capsules than those taking a placebo.*

This is a description of Venlafaxine Extended-Release Tablets, each containing 150mg of venlafaxine hydrochloride. There are 500 tablets in the container, and it is instructed to store them at a temperature between 25°C-30°C to protect from moisture and humidity. The manufacturer is Ascent Pharmaceuticals in Central Islip, NY 11722. It is mentioned to check the medication guide each time the extended-release tablet is dispensed.*

This is a medication called Venlafaxine that comes in a bottle of 500 extended-release tablets, with each tablet containing 225 mg of venlafaxine hydrochloride. The usual dosage is one tablet per day. The authorized dispenser must give the patient a medication guide with each dispensation. The medication should be stored at a temperature between 15°C to 30°C and protected from moisture and humidity. This medication is manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY.*

This is a label of Venlafaxine Extended-Release Tablets, containing 500 tablets, each of which has Venlataxae Bydrochloride equivalent to a certain amount of milligrams. The tablets are to be dispensed by an authorized dispenser only, and the patient is advised to refer to the attached medication guide. The usual dosage is once daily, and it is recommended to store the tablets at a temperature limit of 15° - 30°C (59° - 86°F) and protect them from moisture and humidity. The manufacturer of these tablets is Ascent Pharmaceuticals, Inc, located in Central Islip, NY 11722.*

This is a description of a medication with NDC number 43602-393.05. It contains 75 mg Venlafaxine Hydrochloride which is an antidepressant. It can be taken once daily as an extended-release tablet. Information about the dosage is available in the package insert. The medication should be stored at room temperature between 15 - 30°C (59° - 86°F) and protected from moisture and humidity. This medication is available only with a prescription.*